1,444
Views
20
CrossRef citations to date
0
Altmetric
Original Research

The Effect of Mindfulness-Based Stress Reduction (MBSR) on Depression, Cognition, and Immunity in Mild Cognitive Impairment: A Pilot Feasibility Study

, ORCID Icon, , ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1365-1381 | Published online: 12 Aug 2020

References

  • Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75. doi:10.1016/j.jalz.2012.11.00723305823
  • Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to alzheimer’s disease: recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.00821514249
  • Orgeta V, Qazi A, Spector A, Orrell M. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis. Br J Psychiat. 2015;207(4):293–298. doi:10.1192/bjp.bp.114.148130
  • Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288(12):1475–1483. doi:10.1001/jama.288.12.147512243634
  • Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 2009;72(24):2115–2121. doi:10.1212/WNL.0b013e3181aa52d319528519
  • Franceschi C, Bonafè M, Valensin S, et al. Inflamm‐aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908(1):244–254. doi:10.1111/j.1749-6632.2000.tb06651.x10911963
  • Di Benedetto S, Müller L, Wenger E, Düzel S, Pawelec G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci Biobehav Rev. 2017;75:114–128. doi:10.1016/j.neubiorev.2017.01.04428161508
  • Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14(12):877–882. doi:10.1016/j.jamda.2013.05.00923792036
  • Giunta B, Fernandez F, Nikolic WV, et al. Inflammaging as a prodrome to alzheimer’s disease. J Neuroinflammation. 2008;5(1):51. doi:10.1186/1742-2094-5-5119014446
  • Tao Q, Ang TF, DeCarli C, et al. Association of chronic low-grade inflammation with risk of alzheimer disease in ApoE4 carriers. JAMA netw open. 2018;1(6):e183597. doi:10.1001/jamanetworkopen.2018.359730646251
  • Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in alzheimer’s disease, role of cytokines. Sci World J. 2012;2012.
  • Le Page A, Garneau H, Dupuis G, et al. Differential phenotypes of myeloid-derived suppressor and T regulatory cells and cytokine levels in amnestic mild cognitive impairment subjects compared to mild alzheimer diseased patients. Front Immunol. 2017;8:783. doi:10.3389/fimmu.2017.0078328736551
  • Le Page A, Lamoureux J, Bourgade K, et al. Polymorphonuclear neutrophil functions are differentially altered in amnestic mild cognitive impairment and mild alzheimer’s disease patients. Journal of Alzheimer’s Disease. 2017;60(1):23–42. doi:10.3233/JAD-170124
  • Griciuc A, Serrano-Pozo A, Parrado AR, et al. Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631–643. doi:10.1016/j.neuron.2013.04.01423623698
  • Bradshaw EM, Chibnik LB, Keenan BT, et al. CD33 alzheimer’s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16(7):848–850. doi:10.1038/nn.343523708142
  • Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–308. doi:10.1001/archneur.56.3.30310190820
  • Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014;312(23):2551–2561. doi:10.1001/jama.2014.1380625514304
  • Horrigan BJ. New studies support the therapeutic value of meditation. Explore. 2007;3(5):449–452. doi:10.1016/j.explore.2007.07.00317905353
  • Marciniak R, Sheardova K, Čermáková P, Hudeček D, Šumec R, Hort J. Effect of meditation on cognitive functions in context of aging and neurodegenerative diseases. Front Behav Neurosci. 2014;8:17. doi:10.3389/fnbeh.2014.0001724478663
  • Kurth F, Cherbuin N, Luders E. Reduced age-related degeneration of the hippocampal subiculum in long-term meditators. Psychiatry Res. 2015;232(3):214–218. doi:10.1016/j.pscychresns.2015.03.00825907419
  • Gard T, Hölzel BK, Lazar SW. The potential effects of meditation on age-related cognitive decline: a systematic review. Ann N Y Acad Sci. 2014;1307:89. doi:10.1111/nyas.1234824571182
  • Tang YY, Hölzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16(4):213–225. doi:10.1038/nrn391625783612
  • Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015;37:1–2. doi:10.1016/j.cpr.2015.01.00625689576
  • Hofmann SG, Gómez AF. Mindfulness-based interventions for anxiety and depression. Psychiatr Clin. 2017;40(4):739–749. doi:10.1016/j.psc.2017.08.008
  • Innes KE, Selfe TK, Brown CJ, Rose KM, Thompson-Heisterman A. The effects of meditation on perceived stress and related indices of psychological status and sympathetic activation in persons with alzheimer’s disease and their caregivers: a pilot study. Evid Based Complement Alternat Med. 2012;2012. doi:10.1155/2012/927509
  • Khalsa DS, Ashford JW. Stress, meditation, and alzheimer’s disease prevention: where the evidence stands. J Alzheimers Dis. 2015;48(1):1–2. doi:10.3233/JAD-14276626445019
  • Russell-Williams J, Jaroudi W, Perich T, Hoscheidt S, El Haj M, Moustafa AA. Mindfulness and meditation: treating cognitive impairment and reducing stress in dementia. Rev Neurosci. 2018;29(7):791–804. doi:10.1515/revneuro-2017-006629466242
  • Newberg AB, Serruya M, Wintering N, Moss AS, Reibel D, Monti DA. Meditation and neurodegenerative diseases. Ann N Y Acad Sci. 2014;1307(1):112–123. doi:10.1111/nyas.1218723924172
  • Newberg AB, Wintering N, Khalsa DS, Roggenkamp H, Waldman MR. Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study. J Alzheimers Dis. 2010;20(2):517–526. doi:10.3233/JAD-2010-139120164557
  • Grant JA, Courtemanche J, Duerden EG, Duncan GH, Rainville P. Cortical thickness and pain sensitivity in zen meditators. Emotion. 2010;10(1):43. doi:10.1037/a001833420141301
  • Luders E, Clark K, Narr KL, Toga AW. Enhanced brain connectivity in long-term meditation practitioners. Neuroimage. 2011;57(4):1308–1316. doi:10.1016/j.neuroimage.2011.05.07521664467
  • Wells RE, Yeh GY, Kerr CE, et al. Meditation’s impact on default mode network and hippocampus in mild cognitive impairment: a pilot study. Neurosci Lett. 2013;556:15–19. doi:10.1016/j.neulet.2013.10.00124120430
  • Kabat-Zinn J. Full Catastrophe Living, Revised Edition: How to Cope with Stress, Pain and Illness Using Mindfulness Meditation. Hachette UK; 2013.
  • Kabat-Zinn J. Wherever You Go, There You Are: Mindfulness Meditation in Everyday Life. Hachette Books; 2009.
  • Crane RS. Implementing mindfulness in the mainstream: making the path by walking it. Mindfulness. 2017;8(3):585–594. doi:10.1007/s12671-016-0632-728515799
  • Moss AS, Reibel DK, Greeson JM, et al. An adapted mindfulness-based stress reduction program for elders in a continuing care retirement community: quantitative and qualitative results from a pilot randomized controlled trial. J Appl Gerontol. 2015;34(4):518–538. doi:10.1177/073346481455941125492049
  • Creswell JD, Irwin MR, Burklund LJ, et al. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun. 2012;26(7):1095–1101. doi:10.1016/j.bbi.2012.07.00622820409
  • Ernst S, Welke J, Heintze C, et al. Effects of mindfulness-based stress reduction on quality of life in nursing home residents: a feasibility study. Complement Med Res. 2008;15(2):74–81. doi:10.1159/000121479
  • Larouche E, Hudon C, Goulet S. Mindfulness mechanisms and psychological effects for aMCI patients: a comparison with psychoeducation. Complement Ther Clin Pract. 2019;34:93–104. doi:10.1016/j.ctcp.2018.11.00830712752
  • Siang-Ted K, Fam J, Feng L, et al. Mindfulness modulates biomarkers and cognition in elderly with mild cognitive impairment (MCI): a randomized controlled trial (RCT). Psychoneuroendocrinology. 2017;83:46. doi:10.1016/j.psyneuen.2017.07.363
  • Wong WP, Coles J, Chambers R, Wu DB, Hassed C. The effects of mindfulness on older adults with mild cognitive impairment. J Alzheimers Dis Rep. 2017;1(1):181–193. doi:10.3233/ADR-17003130480237
  • Zanesco AP, King BG, MacLean KA, Saron CD. Cognitive aging and long-term maintenance of attentional improvements following meditation training. Journal of Cognitive Enhancement. 2018;2(3):259–275. doi:10.1007/s41465-018-0068-1
  • Kaliman P, Alvarez-Lopez MJ, Cosín-Tomás M, Rosenkranz MA, Lutz A, Davidson RJ. Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators. Psychoneuroendocrinology. 2014;40:96–107. doi:10.1016/j.psyneuen.2013.11.00424485481
  • Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016;1373(1):13. doi:10.1111/nyas.1299826799456
  • Hearps AC, Martin GE, Angelovich TA, et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell. 2012;11(5):867–875. doi:10.1111/j.1474-9726.2012.00851.x22708967
  • Wong KL, Yeap WH, Tai JJY, Ong SM, Dang TM, Wong SC. The three human monocyte subsets: implications for health and disease. Immunol Res. 2012;53(1–3):41–57. doi:10.1007/s12026-012-8297-322430559
  • Ziegler‐Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81(3):584–592. doi:10.1189/jlb.080651017135573
  • Jose SS, Bendickova K, Kepak T, Krenova Z, Fric J. Chronic inflammation in immune aging: role of pattern recognition receptor crosstalk with the telomere complex? Front Immunol. 2017;8:1078. doi:10.3389/fimmu.2017.0107828928745
  • Wells RE, Kerr CE, Wolkin J, et al. Meditation for adults with mild cognitive impairment: a pilot randomized trial. J Am Geriatr Soc. 2013;61(4):642–645. doi:10.1111/jgs.1217923581918
  • Astin JA. Stress reduction through mindfulness meditation. Psychother Psychosom. 1997;66(2):97–106. doi:10.1159/0002891169097338
  • Shapiro SL, Schwartz GE, Bonner G. Effects of mindfulness-based stress reduction on medical and premedical students. J Behav Med. 1998;21(6):581–599. doi:10.1023/A:10187008298259891256
  • Schure MB, Christopher J, Christopher S. Mind–body medicine and the art of self‐care: teaching mindfulness to counseling students through yoga, meditation, and qigong. J Couns Dev. 2008;86(1):47–56.
  • Greeson JM, Webber DM, Smoski MJ, et al. Changes in spirituality partly explain health-related quality of life outcomes after mindfulness-based stress reduction. J Behav Med. 2011;34(6):508–518. doi:10.1007/s10865-011-9332-x21360283
  • Carmody J, Baer RA. Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J Behav Med. 2008;31(1):23–33. doi:10.1007/s10865-007-9130-717899351
  • Birnie K, Speca M, Carlson LE. Exploring self‐compassion and empathy in the context of mindfulness‐based stress reduction (MBSR). Stress Health. 2010;26(5):359–371. doi:10.1002/smi.1305
  • Moss AS, Wintering N, Roggenkamp H, et al. Effects of an 8-week meditation program on mood and anxiety in patients with memory loss. J Altern Complement Med. 2012;18(1):48–53. doi:10.1089/acm.2011.005122268968
  • Kaufman Y, Anaki D, Binns M, Freedman M. Cognitive decline in alzheimer disease: impact of spirituality, religiosity, and QOL. Neurology. 2007;68(18):1509–1514. doi:10.1212/01.wnl.0000260697.66617.5917470754
  • Hosseini S, Chaurasia A, Oremus M. The effect of religion and spirituality on cognitive function: a systematic review. Gerontologist. 2019;59(2):76–85. doi:10.1093/geront/gnx024
  • Coin A, Perissinotto E, Najjar M, et al. Does religiosity protect against cognitive and behavioral decline in alzheimer’s dementia? Curr Alzheimer Res. 2010;7(5):445–452. doi:10.2174/15672051079138388620088813
  • Maruff P, Lim YY, Darby D, et al. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and alzheimer’s disease. BMC Psychol. 2013;1(1):30. doi:10.1186/2050-7283-1-3025566378
  • Sheardova K, Vyhnalek M, Nedelska Z, et al. Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic. BMJ Open. 2019;9(12):e030379. doi:10.1136/bmjopen-2019-030379
  • Mozolic JL, Long AB, Morgan AR, Rawley-Payne M, Laurienti PJ. A cognitive training intervention improves modality-specific attention in a randomized controlled trial of healthy older adults. Neurobiol Aging. 2011;32(4):655–668. doi:10.1016/j.neurobiolaging.2009.04.01319428142
  • Legault C, Jennings JM, Katula JA, et al., SHARP-P Study Group. Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trial. BMC Geriatr. 2011;11(1):27. doi:10.1186/1471-2318-11-2721615936
  • Smith GE, Housen P, Yaffe K, et al. A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity‐based Adaptive Cognitive Training (IMPACT) Study. J Am Geriatr Soc. 2009;57(4):594–603. doi:10.1111/j.1532-5415.2008.02167.x19220558
  • Santorelli SF, Kabat-Zinn J, Blacker M, Meleo-Meyer F, Koerbel L. Mindfulness-Based Stress Reduction (MBSR) Authorized Curriculum Guide. Center for Mindfulness in Medicine, Health Care, and Society (CFM). University of Massachusetts Medical School; 2017.
  • Gates NJ, Sachdev PS, Singh MA, Valenzuela M. Cognitive and memory training in adults at risk of dementia: a systematic review. BMC Geriatr. 2011;11(1):55. doi:10.1186/1471-2318-11-5521942932
  • Kelly ME, Loughrey D, Lawlor BA, Robertson IH, Walsh C, Brennan S. The impact of cognitive training and mental stimulation on cognitive and everyday functioning of healthy older adults: a systematic review and meta-analysis. Ageing Res Rev. 2014;15:28–43. doi:10.1016/j.arr.2014.02.00424607830
  • Suchá J. Cvičení paměti pro každý věk: testy na paměť a logiku. Portál; 2007.
  • Suchá J. Skupinové hry pro cvičení paměti v každém věku. Portál; 2012.
  • Bílková J. Kognitivní Trénink pro třetí věk: 100 cvičení pro rozvoj koncentrace, kreativity, paměti a verbálních dovedností. Grada; 2016.
  • Bezdicek O, Lukavsky J, Stepankova H, et al. The Prague Stroop test: normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson’s disease. J Clin Exp Neuropsychol. 2015;37(8):794–807. doi:10.1080/13803395.2015.105710626313510
  • Bezdicek O, Libon DJ, Stepankova H, et al. Development, validity, and normative data study for the 12-word Philadelphia verbal learning test [czP (r) VLT-12] among older and very old Czech adults. Clin Neuropsychol. 2014;28(7):1162–1181. doi:10.1080/13854046.2014.95266625247611
  • Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14(2):167–177.14590600
  • Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986.
  • Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893. doi:10.1037/0022-006X.56.6.8933204199
  • Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74–e80. doi:10.1182/blood-2010-02-25855820628149
  • Fisher J. Development and application of a spiritual well-being questionnaire called SHALOM. Religions. 2010;1(1):105–121. doi:10.3390/rel1010105
  • Marciniak R, Serek J, Sheardova K, Hudecek D, Hort J. SHALOM questionnaire psychometric characteristics of elderly Czech population. Cesk Psychol. 2017;61(3):230–244.
  • Tan J, Tsakok FH, Ow EK, et al. Study protocol for a randomized controlled trial of choral singing intervention to prevent cognitive decline in at-risk older adults living in the community. Front Aging Neurosci. 2018;10:195. doi:10.3389/fnagi.2018.0019530042673
  • Sellami M, Gasmi M, Denham J, et al. Effects of acute and chronic exercise on immunological parameters in the elderly aged: can physical activity counteract the effects of aging? Front Immunol. 2018;9:2187. doi:10.3389/fimmu.2018.0218730364079
  • Makizako H, Tsutsumimoto K, Doi T, et al. Effects of exercise and horticultural intervention on the brain and mental health in older adults with depressive symptoms and memory problems: study protocol for a randomized controlled trial [UMIN000018547]. Trials. 2015;16(1):499. doi:10.1186/s13063-015-1032-326537979
  • Panza F, Frisardi V, Capurso C, et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry. 2010;18(2):98–116. doi:10.1097/JGP.0b013e3181b0fa1320104067
  • Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis. 2009;18(1):11–30. doi:10.3233/JAD-2009-112019542627
  • Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and alzheimer disease. Am J Geriatr Psychiatry. 2013;21(7):685–695. doi:10.1016/j.jagp.2013.01.00623567400
  • Larouche E, Hudon C, Goulet S. Potential benefits of mindfulness-based interventions in mild cognitive impairment and alzheimer’s disease: an interdisciplinary perspective. Behav Brain Res. 2015;276:199–212. doi:10.1016/j.bbr.2014.05.05824893317
  • Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29(4):448–474. doi:10.1016/S0306-4530(03)00054-414749092
  • Matousek RH, Pruessner JC, Dobkin PL. Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer. Complement Ther Clin Pract. 2011;17(2):65–70. doi:10.1016/j.ctcp.2010.10.00521457893
  • Bränström R, Kvillemo P, Åkerstedt T. Effects of mindfulness training on levels of cortisol in cancer patients. Psychosomatics. 2013;54(2):158–164. doi:10.1016/j.psym.2012.04.00723218058
  • Carlson LE, Doll R, Stephen J, et al. Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer. J Clin Oncol. 2013;31(25):3119–3126. doi:10.1200/JCO.2012.47.521023918953
  • Marcus MT, Fine PM, Moeller FG, et al. Change in stress levels following mindfulness-based stress reduction in a therapeutic community. Addict Disord Their Treat. 2003;2(3):63–68. doi:10.1097/00132576-200302030-00001
  • Kox M, Stoffels M, Smeekens SP, et al. The influence of concentration/meditation on autonomic nervous system activity and the innate immune response: a case study. Psychosom Med. 2012;74(5):489–494. doi:10.1097/PSY.0b013e3182583c6d22685240
  • Rosenkranz MA, Davidson RJ, MacCoon DG, Sheridan JF, Kalin NH, Lutz A. A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav Immun. 2013;27:174–184. doi:10.1016/j.bbi.2012.10.01323092711
  • Bhasin MK, Dusek JA, Chang BH, et al. Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS One. 2013;8(5). doi:10.1371/journal.pone.0062817
  • Black DS, Cole SW, Irwin MR, et al. Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology. 2013;38(3):348–355. doi:10.1016/j.psyneuen.2012.06.01122795617
  • Rodriguez JJ, Noristani HN, Verkhratsky A. The serotonergic system in ageing and alzheimer’s disease. Prog Neurobiol. 2012;99(1):15–41. doi:10.1016/j.pneurobio.2012.06.01022766041
  • Bujatti M, Riederer P. Serotonin, noradrenaline, dopamine metabolites in transcendental meditation-technique. J Neural Transm. 1976;39(3):257–267. doi:10.1007/BF1256514789821
  • Schutte NS, Malouff JM. A meta-analytic review of the effects of mindfulness meditation on telomerase activity. Psychoneuroendocrinology. 2014;42:45–48. doi:10.1016/j.psyneuen.2013.12.01724636500
  • Yadav RK, Ray RB, Vempati R, Bijlani RL. Effect of a comprehensive yoga-based lifestyle modification program on lipid peroxidation. Indian J Physiol Pharmacol. 2005;49:358–362.16440857
  • Schneider RH, Nidich SI, Salerno JW, et al. Lower lipid peroxide levels in practitioners of the transcendental meditation [registered sign] program. Psychosom Med. 1998;60(1):38–41. doi:10.1097/00006842-199801000-000089492237
  • Kim DH, Moon YS, Kim HS, et al. Effect of zen meditation on serum nitric oxide activity and lipid peroxidation. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(2):327–331. doi:10.1016/j.pnpbp.2004.11.01915694242
  • Sinha S, Singh SN, Monga YP, Ray US. Improvement of glutathione and total antioxidant status with yoga. J Altern Complement Med. 2007;13(10):1085–1090. doi:10.1089/acm.2007.056718166119
  • Sharma H, Datta P, Singh A, et al. Gene expression profiling in practitioners of Sudarshan Kriya. J Psychosom Res. 2008;64(2):213–218. doi:10.1016/j.jpsychores.2007.07.00318222135
  • Dusek JA, Otu HH, Wohlhueter AL, et al. Genomic counter-stress changes induced by the relaxation response. PLoS One. 2008;3(7):e2576. doi:10.1371/journal.pone.000257618596974
  • Martarelli D, Cocchioni M, Scuri S, Pompei P. Diaphragmatic breathing reduces postprandial oxidative stress. J Altern Complement Med. 2011;17(7):623–628. doi:10.1089/acm.2010.066621688985
  • Gallegos AM, Hoerger M, Talbot NL, et al. Toward identifying the effects of the specific components of mindfulness-based stress reduction on biologic and emotional outcomes among older adults. J Altern Complement Med. 2013;19(10):787–792. doi:10.1089/acm.2012.002823383976
  • Hölzel BK, Carmody J, Vangel M, et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res. 2011;191(1):36–43. doi:10.1016/j.pscychresns.2010.08.00621071182
  • Fox KC, Nijeboer S, Dixon ML, et al. Is meditation associated with altered brain structure? A systematic review and meta-analysis of morphometric neuroimaging in meditation practitioners. Neurosci Biobehav Rev. 2014;43:48–73. doi:10.1016/j.neubiorev.2014.03.01624705269
  • Malinowski P. Neural mechanisms of attentional control in mindfulness meditation. Front Neurosci. 2013;7:8. doi:10.3389/fnins.2013.0000823382709
  • Malinowski P, Shalamanova L. Meditation and cognitive ageing: the role of mindfulness meditation in building cognitive reserve. Journal of Cognitive Enhancement. 2017;1(2):96–106. doi:10.1007/s41465-017-0022-7
  • Kertzman S, Reznik I, Hornik-Lurie T, Weizman A, Kotler M, Amital D. Stroop performance in major depression: selective attention impairment or psychomotor slowness? J Affect Disord. 2010;122(1–2):167–173. doi:10.1016/j.jad.2009.08.00919732958
  • Rosenberg PB, Mielke MM, Xue QL, Carlson MC. Depressive symptoms predict incident cognitive impairment in cognitive healthy older women. Am J Geriatr Psychiatry. 2010;18(3):204–211. doi:10.1097/JGP.0b013e3181c5348720224517
  • Feliu‐Soler A, Pérez‐Aranda A, Andrés‐Rodríguez L, et al. Digging into the construct of fibrofog: psychometric properties of the Spanish version of the multidimensional inventory of subjective cognitive impairment in patients with fibromyalgia. J Appl Biobehav Res. 2018;23(2):12134. doi:10.1111/jabr.12134
  • Gilbertson MW, Shenton ME, Ciszewski A, et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci. 2002;5(11):1242–1247. doi:10.1038/nn95812379862
  • Wager-Smith K, Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neurosci Biobehav Rev. 2011;35(3):742–764. doi:10.1016/j.neubiorev.2010.09.01020883718
  • Heneka MT, O’Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in alzheimer’s disease. J Neural Transm. 2010;117(8):919–947.20632195
  • Lao SA, Kissane D, Meadows G. Cognitive effects of MBSR/MBCT: a systematic review of neuropsychological outcomes. Conscious Cogn. 2016;45:109–123. doi:10.1016/j.concog.2016.08.01727580462
  • Quintana-Hernandez DJ, Miro-Barrachina MT, Ibanez-Fernandez IJ, et al. Mindfulness in the maintenance of cognitive capacities in alzheimer’s disease: a randomized clinical trial. J Alzheimers Dis. 2016;50(1):217–232. doi:10.3233/JAD-14300926639952
  • Bower JE, Crosswell AD, Stanton AL, et al. Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial. Cancer. 2015;121(8):1231–1240. doi:10.1002/cncr.2919425537522
  • Malarkey WB, Jarjoura D, Klatt M. Workplace based mindfulness practice and inflammation: a randomized trial. Brain Behav Immun. 2013;27:145–154. doi:10.1016/j.bbi.2012.10.00923078984
  • Parsons CE, Crane C, Parsons LJ, Fjorback LO, Kuyken W. Home practice in mindfulness-based cognitive therapy and mindfulness-based stress reduction: a systematic review and meta-analysis of participants’ mindfulness practice and its association with outcomes. Behav Res Ther. 2017;95:29–41. doi:10.1016/j.brat.2017.05.00428527330
  • Alexander C, Langer E, Newman R, Chandler H, Davies J. Aging, mindfulness and meditation. J Pers Soc Psychol. 1989;57:950–964. doi:10.1037/0022-3514.57.6.9502693686
  • Prakash R, Rastogi P, Dubey I, Abhishek P, Chaudhury S, Small BJ. Long-term concentrative meditation and cognitive performance among older adults. Aging Neuropsycholo Cognition. 2012;19(4):479–494. doi:10.1080/13825585.2011.630932
  • Pérez-Aranda A, Feliu-Soler A, Montero-Marín J, et al. A randomized controlled efficacy trial of mindfulness-based stress reduction compared with an active control group and usual care for fibromyalgia: the EUDAIMON study. Pain. 2019;160(11):2508–2523. doi:10.1097/j.pain.000000000000165531356450
  • Eyre HA, Siddarth P, Acevedo B, et al. A randomized controlled trial of Kundalini yoga in mild cognitive impairment. Int Psychogeriatr. 2017;29(4):557–567. doi:10.1017/S104161021600215528088925
  • Innes KE, Selfe TK, Brundage K, et al. Effects of meditation and music-listening on blood biomarkers of cellular aging and alzheimer’s disease in adults with subjective cognitive decline: an exploratory randomized clinical trial. J Alzheimers Dis. 2018;66(3):947–970. doi:10.3233/JAD-18016430320574
  • Innes KE, Selfe TK, Khalsa DS, Kandati S, Ashford JW. Meditation and music improve memory and cognitive function in adults with subjective cognitive decline: a pilot randomized controlled trial. J Alzheimers Dis. 2017;56(3):899–916. doi:10.3233/JAD-16086728106552